Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qizao Oral Liquid for tumor-associated anemia
ChiCTR2300072537Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Feb 2023
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Qizao Oral Liquid in cancer-associated anemia (CRA) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Hemoglobin, Red blood cell count and 12 more. Started Feb 2023; status: recruiting.
02
Drugs
Qizao Oral Liquid
03
Conditions
cancer-associated anemia (CRA)
Beyond the preview
Go deeper on ChiCTR2300072537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072537.